Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05790928 · ClinicalTrials.gov registry record
Air Optix Night and Day Aqua (AONDA) Retrospective Study 1
A clinical trial of Myopia and Hyperopia, sponsored by Alcon Research.
- Completed
- Registry status
- 108
- Enrollment target
- 4
- Study locations
NCT05790928: Completed study of Myopia and Hyperopia, sponsored by Alcon Research.
NCT05790928 is a study of Myopia and Hyperopia that has completed, run by Alcon Research. The registered enrollment target is 108 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (60% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05790928, a study of Myopia and Hyperopia, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- 108 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to assess long term performance and safety of AONDA in a real world setting when worn as daily wear or continuous wear for vision correction. This study will be used to support AONDA's marketability in Europe and other locations.
Primary Outcome
The subject's chart will be reviewed for a distance visual acuity assessment at 1 year after the baseline exam. The 1-year visit will be defined as a visit which occurred 1 year (-2/+4 months) since baseline, during which period the subject was wearing AONDA, and a contact lens examination was performed. Baseline will be defined as the first office visit where the investigator provided an in-person office biomicroscopy exam to the patient, before or during which a contact lens prescription for A
Conditions Studied
Interventions
- DEVICE Lotrafilcon A spherical contact lenses
Study Locations (4)
Florida
- Tallahassee Eye Center - Tallahassee
Illinois
- Franklin Park Eye Center PC - Franklin Park
Minnesota
- The Eye Doctors Inc - Eden Prairie
Tennessee
- Optometry Group, PLLC - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2023-03-25 |
| Est. Completion | 2023-03-31 |
What the finished NCT05790928 record still lists
NCT05790928 is an observational study that tracks outcomes without assigning an intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (60% lower).
The record links to 3 conditions, with Myopia appearing as the primary indexed condition, and to 1 intervention - of which Lotrafilcon A spherical contact lenses is the first listed.
NCT05790928 reports a single indexed study location in Florida, Illinois, Minnesota.
Frequently Asked Questions
What is clinical trial NCT05790928 about?
NCT05790928 is a clinical study titled "Air Optix Night and Day Aqua (AONDA) Retrospective Study 1". The purpose of this study is to assess long term performance and safety of AONDA in a real world setting when worn as daily wear or continuous wear for vision correction. This study will be used to support AONDA's marketability in Europe and other locations.
What is the current status of trial NCT05790928?
This trial is currently completed. The enrollment target is 108 participants. The study started on 2023-03-25. Estimated completion is 2023-03-31.
What conditions does trial NCT05790928 study?
This clinical trial studies the following conditions: Myopia, Hyperopia, Refractive Ametropia.
What interventions are being tested in trial NCT05790928?
The interventions under investigation include: Lotrafilcon A spherical contact lenses (DEVICE).
Who is sponsoring clinical trial NCT05790928?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05790928 being conducted?
This trial has 4 study locations across Florida, Illinois, Minnesota, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05790928's enrollment target sits among peer trials
108 38th of 90 higher than 53 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Clinical Evaluation of WaveLight Plus LASIK
RECRUITING
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI